Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985-2004)

Journal of the American Veterinary Medical Association

Volumn 228, Issue 12, 2006, Pages 1905-1908

  Boston, Sarah E ^a,b   Ehrhart, Nicole P ^a   Dernell, William S ^a   Lafferty, Mary ^a   Withrow, Stephen J ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b Western Veterinary Specialist Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CARBOPLATIN; CISPLATIN; DOXORUBICIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

AGE; ANIMAL DISEASE; ARTICLE; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; GENDER; KAPLAN MEIER METHOD; METASTASIS POTENTIAL; NONHUMAN; OSTEOSARCOMA; RETROSPECTIVE STUDY; SOFT TISSUE METASTASIS; STATISTICAL SIGNIFICANCE; SURVIVAL TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; COLORADO; COMBINED MODALITY THERAPY; DOG DISEASES; DOGS; FEMALE; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; OSTEOSARCOMA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

ANIMALIA; CANIS FAMILIARIS;

EID: 33745031523     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.228.12.1905     Document Type: Article

References (10)

1. Meyers P, Heller G, Healey JH, et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 1993;11:449-453.
2. Kager L, Zoubek A, Pötschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2003;21:2011-2018.
3. Briasoulis E, Karavasillis V, Kostadima L, et al. Metastatic breast carcinoma confined to bone. Cancer 2004;101:1524-1528.
4. Bacci G, Picci P, Ferrari S, et al. Synchronous multifocal osteosarcoma: results in twelve patients treated with neoadjuvant chemotherapy and simultaneous resection of all involved bones. Ann Oncol 1996;7:864-866.
5. Tsunemi T, Nagoya S, Kaya M, et al. Postoperative progression of pulmonary metastasis and osteosarcoma. Clin Orthop Relat Res 2003;407:159-166.
6. Kaya M, Wada T, Nagoya S, et al. Concomitant tumour resistance in patients with osteosarcoma. A clue to a new therapeutic strategy. J Bone Joint Surg Br 2004;86:143-147.
7. Bacci G, Mercuri M, Briccoli A, et al. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Cancer 1997;79:245-254.
8. Picci P, Vanel D, Briccoli A, et al. Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. Ann Oncol 2001; 12:1601-1604.
9. Vanel D, Henry-Amar M, Lumbroso J, et al. Pulmonary evaluation of patients with osteosarcoma: roles of standard radiography, tomography, CT, scintigraphy and tomoscintigraphy. AJR Am J Roentgenol 1984;143:519-523.
10. Chalmers N, Best JJK. The significance of pulmonary nodules detected by CT but not by chest radiography in tumour staging. Clin Radiol 1991;44:410-412.